Louis Edward Tamayo - Chief Financial Officer at Lexeo Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Issuer Symbol
LXEO on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Louis Edward Tamayo since 26 Feb 2025

Holdings reported by Louis Edward Tamayo for Lexeo Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 89,665 $890,373 $9.93 04 Feb 2026 Direct
Stock Option (right to buy) 226,665 04 Feb 2026 Direct Common Stock

Transactions reported by Louis Edward Tamayo for Lexeo Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.